Mechanisms of Cellular Internalization of Quantum Dot® Conjugated Bone Formation Mimetic Peptide CK2.3

Osteoporosis is a debilitating skeletal disorder that is characterized by loss of bone density over time. It affects one in two women and one in four men, age 50 and older. New treatments that specifically drive bone formation are desperately needed. We developed a peptide, CK2.3, that acts downstre...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrathasha, Vrathasha, Booksh, Karl, Duncan, Randall L., Nohe, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071089/
https://www.ncbi.nlm.nih.gov/pubmed/29987256
http://dx.doi.org/10.3390/nano8070513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071089/
https://www.ncbi.nlm.nih.gov/pubmed/29987256
http://dx.doi.org/10.3390/nano8070513

Ejemplares similares